Therapeutic Radiopharmaceuticals

Name
Therapeutic Radiopharmaceuticals
Accession Number
DBCAT002562
Description
Not Available
ATC Classification
Drugs
DrugDrug Description
Ibritumomab tiuxetanA monoclonal anti-CD20 antibody used to treat B-cell non-Hodgkin's lymphoma via a conjugated radioactive isotope.
TositumomabA monoclonal anti-CD20 antibody used to treat B-cell non-Hodgkin's lymphoma via a conjugated radioactive isotope.
Samarium (153Sm) lexidronamA chelated complex of samarium isotope and EDTMP that concentrates in areas with high bone turnover such as sites of metastases to relieve pain associated with osteoblastic metastatic bone lesions.
IobenguaneA radiopharmaceutical agent used for the diagnosis of primary and metastatic pheochromocytoma or neuroblastoma.
Strontium chloride Sr-89A radiopharmaceutical agent used for the relief of bone pain in patients with painful skeletal metastases.
Yttrium Y-90Yttrium 90 has been investigated for the treatment of Colon Cancer and Colorectal Cancer.
Gold Au-198Not Annotated
Rhenium Re-186 sulfideNot Annotated
Iodide I-131A radioisotopic agent used for the treatment of hyperthyroidism and thyroid carcinomas that take up iodine.
Sodium phosphate P 32Not Annotated
Drugs & Drug Targets
DrugTargetType
Ibritumomab tiuxetanB-lymphocyte antigen CD20target
Ibritumomab tiuxetanLow affinity immunoglobulin gamma Fc region receptor III-Btarget
Ibritumomab tiuxetanComplement C1r subcomponenttarget
Ibritumomab tiuxetanComplement C1q subcomponent subunit Atarget
Ibritumomab tiuxetanComplement C1q subcomponent subunit Btarget
Ibritumomab tiuxetanComplement C1q subcomponent subunit Ctarget
Ibritumomab tiuxetanLow affinity immunoglobulin gamma Fc region receptor III-Atarget
Ibritumomab tiuxetanComplement C1s subcomponenttarget
Ibritumomab tiuxetanHigh affinity immunoglobulin gamma Fc receptor Itarget
Ibritumomab tiuxetanLow affinity immunoglobulin gamma Fc region receptor II-atarget
Ibritumomab tiuxetanLow affinity immunoglobulin gamma Fc region receptor II-btarget
Ibritumomab tiuxetanLow affinity immunoglobulin gamma Fc region receptor II-ctarget
TositumomabB-lymphocyte antigen CD20target
TositumomabLow affinity immunoglobulin gamma Fc region receptor III-Btarget
TositumomabComplement C1r subcomponenttarget
TositumomabComplement C1q subcomponent subunit Atarget
TositumomabComplement C1q subcomponent subunit Btarget
TositumomabComplement C1q subcomponent subunit Ctarget
TositumomabLow affinity immunoglobulin gamma Fc region receptor III-Atarget
TositumomabHigh affinity immunoglobulin gamma Fc receptor Itarget
TositumomabLow affinity immunoglobulin gamma Fc region receptor II-atarget
TositumomabLow affinity immunoglobulin gamma Fc region receptor II-btarget
TositumomabLow affinity immunoglobulin gamma Fc region receptor II-ctarget
IobenguaneSodium-dependent noradrenaline transportertransporter
Strontium chloride Sr-89Alkaline phosphatase, placental-likeenzyme
Strontium chloride Sr-89Alkaline phosphatase, tissue-nonspecific isozymeenzyme
Strontium chloride Sr-89Adenosine triphosphate (ATP)enzyme
Strontium chloride Sr-89Sodium/calcium exchanger 1transporter
Strontium chloride Sr-89Voltage-dependent T-type calcium channel subunit alpha-1Itransporter